Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.47 USD | -1.96% | -9.10% | +32.33% |
24/05 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
21/05 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.33% | 285.31Cr | |
+9.83% | 12TCr | |
+10.80% | 11TCr | |
-10.84% | 2.34TCr | |
-1.69% | 2.21TCr | |
-10.23% | 1.83TCr | |
-41.92% | 1.66TCr | |
-15.11% | 1.6TCr | |
+6.62% | 1.4TCr | |
+17.53% | 1.17TCr |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- Insider Sell: Ptc Therapeutics